News Quantified

FGEN – fibrogen, inc (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration [Yahoo! Finance]

Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration

FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit [Yahoo! Finance]

FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit

FibroGen Inc (FGEN) Q3 2025 Earnings Call Highlights: Strategic Moves Bolster Financial ... [Yahoo! Finance]

-9.6%

BEAT

10.8%

BEAT

-2.0%

BEAT

-24.3%

BEAT

Form 4 FIBROGEN INC For: Dec 06 Filed by: DeLucia David

Form 4 FIBROGEN INC For: Dec 06 Filed by: Wettig Thane

Form 4 FIBROGEN INC For: Nov 13 Filed by: Wettig Thane

Form SCHEDULE 13G/A FIBROGEN INC Filed by: ARMISTICE CAPITAL, LLC

Form 10-Q FIBROGEN INC For: Sep 30

Top News Gainers

11/8 FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease 20.6%

9/18 Form 4 FIBROGEN INC For: Sep 17 Filed by: Cotroneo Pat 18.0%

5/9 FibroGen Announces Positive Topline Results from Pooled Safety Analyses of Roxadustat Global Phase 3 Program 13.5%

3/19 FibroGen Inc (NASDAQ: FGEN) had its price target lowered by analysts at Citigroup Inc from $65.00 to $51.00. They now have a "buy" rating on the stock. 12.5%

3/23 Form 4 FIBROGEN INC For: Mar 19 Filed by: KEARNS THOMAS F JR 12.4%

3/26 FibroGen Inc (NASDAQ: FGEN) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. 7.7%

8/26 Fibrogen Announces Passing of CEO Thomas B. Neff, Scientific Innovator and Pioneering Biopharmaceutical Executive 7.4%

2/5 FibroGen Inc (NASDAQ: FGEN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.0%

6/14 Form 4 FIBROGEN INC For: Jun 12 Filed by: Yu K Peony 5.7%

11/14 FibroGen Inc (NASDAQ: FGEN) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 5.3%

Top News Decliners

5/9 Form 8-K FIBROGEN INC For: May 09 -27.0%

11/11 FibroGen Inc (NASDAQ: FGEN) had its "positive" rating re-affirmed by analysts at Mizuho. They now have a $72.00 price target on the stock, up previously from $65.00. -15.5%

3/18 FibroGen Inc (NASDAQ: FGEN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -12.1%

3/2 Form S-3ASR FIBROGEN INC -8.6%

11/4 FibroGen To Report Third Quarter 2019 Financial Results on Monday, November 11, 2019 -7.5%

9/23 Form 4 FIBROGEN INC For: Sep 19 Filed by: Chung Christine -6.8%

8/14 FibroGen Inc (NASDAQ: FGEN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $51.00 price target on the stock. -6.6%

8/8 FibroGen Reports Second Quarter 2019 Financial Results -6.5%

5/6 FibroGen to Report First Quarter 2019 Financial Results -6.0%

3/19 Form 4 FIBROGEN INC For: Mar 06 Filed by: Chung Christine -5.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day